TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹4,373 Cr | ₹3,704 Cr | ₹3,364 Cr | ₹2,824 Cr | ₹2,431 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹4,373 Cr |
| Mar2025 | ₹3,704 Cr |
| Mar2024 | ₹3,364 Cr |
| Mar2023 | ₹2,824 Cr |
| Mar2022 | ₹2,431 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,373 Cr | 18.05 | |
| Mar2025 | ₹3,704 Cr | 10.13 | |
| Mar2024 | ₹3,364 Cr | 19.11 | |
| Mar2023 | ₹2,824 Cr | 16.15 | |
| Mar2022 | ₹2,431 Cr | - | |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹182,649.1 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,468.0 Cr | 1.2% | 4.4% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -2.7% |
-3.6% |
36% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses